Skip to main content

Peer Review reports

From: Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives

Original Submission
1 Feb 2023 Submitted Original manuscript
2 Feb 2023 Author responded Author comments - Farid M. Sroor
Resubmission - Version 2
2 Feb 2023 Submitted Manuscript version 2
19 Feb 2023 Author responded Author comments - Farid M. Sroor
Resubmission - Version 3
19 Feb 2023 Submitted Manuscript version 3
8 Apr 2023 Reviewed Reviewer Report
21 Jun 2023 Reviewed Reviewer Report - Youstina William Rizzk
26 Jun 2023 Reviewed Reviewer Report
19 Jul 2023 Author responded Author comments - Farid M. Sroor
Resubmission - Version 4
19 Jul 2023 Submitted Manuscript version 4
20 Jul 2023 Author responded Author comments - Farid M. Sroor
Resubmission - Version 5
20 Jul 2023 Submitted Manuscript version 5
2 Aug 2023 Reviewed Reviewer Report - Youstina William Rizzk
3 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
7 Aug 2023 Editorially accepted
28 Aug 2023 Article published 10.1186/s13065-023-01014-0

You can find further information about peer review here.

Back to article page